You are here

  • Home
  • Archive
  • Volume 75, Issue 12
  • Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

 

Online download statistics by month:

Online download statistics by month: June 2016 to April 2023

AbstractFullPdf
Jun 201682845147
Jul 20162323750
Aug 20161452735
Sep 2016771824
Oct 2016822924
Nov 2016142553288
Dec 201666233117
Jan 20173022752
Feb 20171192230
Mar 20171092822
Apr 2017502618
May 2017783323
Jun 2017731017
Jul 2017911515
Aug 201785178
Sep 2017731512
Oct 20171233016
Nov 2017841313
Dec 201773911
Jan 20181161212
Feb 20181281315
Mar 20188034
Apr 2018361310
May 201873119
Jun 20185696
Jul 20186263
Aug 20185795
Sep 20184353
Oct 2018401410
Nov 20188841
Dec 20184153
Jan 20192262
Feb 20195295
Mar 2019421010
Apr 201964138
May 201941148
Jun 20193795
Jul 201955126
Aug 20195354
Sep 20192875
Oct 201973159
Nov 201964128
Dec 20194672
Jan 20206574
Feb 20203873
Mar 202011983
Apr 20203055
May 202058118
Jun 20204563
Jul 202068137
Aug 20202052
Sep 20207965
Oct 20205574
Nov 20204332
Dec 20209632
Jan 20216483
Feb 20216364
Mar 2021104148
Apr 2021163103
May 20213199
Jun 202114105
Jul 202110107
Aug 2021658
Sep 2021973
Oct 20211191310
Nov 202110097
Dec 20219350
Jan 202281115
Feb 202281133
Mar 202241112
Apr 20225432
May 20227352
Jun 2022109147
Jul 20223945
Aug 20226651
Sep 20229170
Oct 20228251
Nov 20228073
Dec 20223410
Jan 202386107
Feb 2023152122
Mar 20234242
Apr 20234493
Total875510181235